Clinical Trials Logo

Acute Pancreatitis clinical trials

View clinical trials related to Acute Pancreatitis.

Filter by:

NCT ID: NCT02692391 Completed - Acute Pancreatitis Clinical Trials

A Randomized Controlled Pilot Trial of Indomethacin in Acute Pancreatitis

Start date: July 2013
Phase: Phase 3
Study type: Interventional

This is a randomized, double-blind, placebo-controlled pilot trial seeking to evaluate the efficacy of rectal indomethacin in abrogating systemic inflammation and subsequently organ failure and mortality in patients with AP and positive SIRS score.

NCT ID: NCT02622854 Completed - Acute Pancreatitis Clinical Trials

Plasma Exchange vs Conservative Management in Non-severe Acute Hypertriglyceridemic Pancreatitis

Start date: June 2016
Phase: N/A
Study type: Interventional

To compare effectiveness in reducing triglycerides between daily plasma exchange and glucose+insulin infusion in patients with non-severe acute hypertriglyceridemic pancreatitis with mildly elevated triglycerides

NCT ID: NCT02617199 Recruiting - Acute Pancreatitis Clinical Trials

Epidural Anesthesia in Acute Pancreatitis

Start date: November 2015
Phase: Phase 2/Phase 3
Study type: Interventional

Acute pancreatitis is a common urgency with a mortality rate of up to 30% , decreased blood flow in the pancreatic microcirculation. It seems to be the main cause of the pathophysiology of acute pancreatitis. Today, there have been many attempts in the management of pancreatitis but no established management seems to be ideal. The epidural block is an anesthetic technique used to provide highly peri and post-operative analgesia, also plays an important role in improving the gastrointestinal vascular perfusion (due to sympathetic blockade that this technique produces) so this anesthetic technique is proposed as an alternative to both clinical treatment as an analgesic for acute pancreatitis.

NCT ID: NCT02602808 Completed - Acute Pancreatitis Clinical Trials

Study of Peripheral Blood Non-coding RNAs as Diagnosis and Prognosis Biomarker for Acute Pancreatitis

NCRNAP
Start date: December 2015
Phase:
Study type: Observational

It is important to identify patients with acute pancreatitis who are at risk for developing persistent organ failure early in the course of disease. The investigators evaluated whether peripheral blood non-coding RNAs, including microRNAs and long noncoding RNA (lncRNA), could serve as a good marker for detection of acute pancreatitis with persistent organ failure at early phase.

NCT ID: NCT02563080 Completed - Acute Pancreatitis Clinical Trials

Pancreatic Exocrine Insufficiency in Acute Pancreatitis

APPEI
Start date: September 2015
Phase:
Study type: Observational [Patient Registry]

Severe pancreatitis induces more damage in the pancreas and might therefore result reduced exocrine function leading to the insufficiency. The aim of this prospective study is to investigate development of pancreatic exocrine insufficiency in patients recovering from first attack of moderately severe or severe acute pancreatitis.

NCT ID: NCT02543658 Completed - Acute Pancreatitis Clinical Trials

Neostigmine Treatment of Acute Pancreatitis Combined With Intra-abdominal Hypertension

Start date: September 1, 2015
Phase: Phase 2
Study type: Interventional

Acute pancreatitis(A) often complicated with Intra-abdominal Hypertension. After the onset of acute pancreatitis, capillary leakage causing ascites,upper gastrointestinal tract obstruction and paralytic ileus leading to an elevated IAP, severe IAH leads to ACS with high mortality. Neostigmine is an anti-cholinesterase drugs, can enhance intestinal peristalsis, promote flatus defecation. The aim of this study was to determine the effect of neostigmine on reducing abdominal pressure and clinical prognosis in patients with AP by promoting intestinal peristalsis and defecation.

NCT ID: NCT02373293 Recruiting - Acute Pancreatitis Clinical Trials

Study to Assess the Prognostic Value of the Antithrombin III in the Acute Pancreatitis (AT-PROPANC)

AT-PROPANC
Start date: January 18, 2015
Phase: N/A
Study type: Observational

This is an epidemiological, observational, prospective, multicentric study in 400 adult patients admitted to hospital for mild acute pancreatitis to to assess the prognostic value of the antithrombin III in the development of moderate or severe acute pancreatitis.

NCT ID: NCT02318147 Recruiting - Acute Pancreatitis Clinical Trials

Fecal Microbiota Transplantation for Pancreatitis With Infectious Complications(FMTPIC)

Start date: November 2016
Phase: Phase 1
Study type: Interventional

Infectious complications are responsible for most of deaths in acute pancreatitis.Intestinal barrier dysfunction and increased intestinal permeability was associated with bacterial translocation which is believed to prompted these infections.The purpose of this clinical trail is to observe the potential capability of FMT in reduce the bacterial translocation and alleviate infectious complications by the reconstruction of a gut functional state.

NCT ID: NCT02318134 Completed - Acute Pancreatitis Clinical Trials

Fecal Microbiota Transplantation for Pancreatitis

FMTP
Start date: November 18, 2017
Phase: Phase 2
Study type: Interventional

The intestinal microbiota plays a pivotal role in the maintenance of intestinal homeostasis and protecting the gut against pathogens by competing for nutrients, creating the intestinal biological barrier and modulating the host immune system.After the onset of acute pancreatitis,the intestinal hypoperfusion and the release of inflammatory mediators result in intestinal barrier dysfunction and intestinal bacteria dysbiosis.This leads to Bacterial and endotoxin translocation, which may cause infectious complications which are major causes of death in SAP patients.Recently,FMT was shown its efficacy in the treatment of gastrointestinal(GI) diseases and non-GI disorders associated with Intestinal flora disturbance by re-establishing the damaged Intestinal Bacteria homeostasis.However,the mechanism by which FMT results in cure of diseases has been poorly understood.This study aims to investigate the therapeutic potential of FMT for SAP patients with intestinal barrier dysfunction.

NCT ID: NCT02223325 Active, not recruiting - Acute Pancreatitis Clinical Trials

Evaluation of Prognosis and Prognostic Scores in Geriatric Patients With Acute Pancreatitis

Start date: August 2014
Phase: N/A
Study type: Observational

- To compare the prognosis of acute pancreatitis between geriatric and other adult patients - To evaluate the efficacy of various prognostic scores in geriatric patients with acute pancreatitis